Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shares of Merck & Co. Inc. MRK inched 0.08% higher to $99.45 Tuesday, on what proved to be an all-around favorable trading ...

A Fremont pharmaceutical company received an investment of approximately $50 million in a private placement from Merck & Co.

A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.56 per share — in a private ...

Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, ...

We recently published a list of 10 Cheap NYSE Stocks To Invest In Now. In this article, we are going to take a look at where ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $99.45 which represents a slight increase of $0.08 or 0.08% from the prior close of $99.37. The stock opened at $99.22 and touched a ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.05 which represents a decrease of $-1.47 or -1.48% from the prior close of $99.52. The stock opened at $98.83 and touched a ...

Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.